Over the 90-day window ending February 10, 2026, Century Therapeutics's three dominant insider ownership positions are held by TenPercentOwner Aktiengesellschaft Bayer (12.68Mn shares), TenPercentOwner Venture Capital Vi, L.P. Versant (12.17Mn shares), TenPercentOwner Cellular Dynamics, Inc. Fujifilm (6.96Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Aktiengesellschaft Bayer | 12,675,838 | 23 Jun, 2021 | |
| Venture Capital Vi, L.P. Versant | 12,166,109 | 11 Aug, 2022 | |
| Cellular Dynamics, Inc. Fujifilm | 6,955,207 | 23 Jun, 2021 | |
| Brent Pfeiffenberger | President And Ceo | 3,797,990 | 04 Feb, 2026 |
| Eli Casdin | 3,206,380 | 22 Jun, 2021 | |
| Chad Cowan | Chief Scientific Officer | 1,178,476 | 04 Feb, 2026 |
| Gregory Russotti | Nan | 525,982 | 04 Feb, 2026 |
| Douglas Carr | Svp Finance & Operations | 514,551 | 05 Feb, 2026 |
| Luis Borges | Chief Scientific Officer | 256,535 | 05 Apr, 2023 |
| Michael Craig Diem | Chief Financial Officer | 253,533 | 03 Nov, 2023 |
| Adrienne Farid | Chief Operations Officer | 250,141 | 11 Jun, 2025 |
| Morgan Conn | Chief Finanical Officer | 79,648 | 12 Mar, 2025 |
| Hyam Levitsky | President Of R&D | 24,000 | 11 Mar, 2024 |
| Daphne Quimi | 5,000 | 16 Sep, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Feb, 2026 | Douglas Carr | Common Stock | D | 323 | $1.82 | 514,551 | D | S |
| 02 Feb, 2026 | Douglas Carr | Common Stock | A | 110,000 | $0.00 | 514,874 | D | A |
| 02 Feb, 2026 | Gregory Russotti | Common Stock | A | 135,000 | $0.00 | 525,982 | D | A |
| 02 Feb, 2026 | Brent Pfeiffenberger | Common Stock | A | 475,000 | $0.00 | 3,797,990 | D | A |
| 02 Feb, 2026 | Chad Cowan | Common Stock | A | 135,000 | $0.00 | 1,178,476 | D | A |
| 02 Jan, 2026 | Chad Cowan | Common Stock | D | 1,611 | $1.00 | 1,043,476 | D | F |
| 22 Dec, 2025 | Chad Cowan | Common Stock | A | 58,060 | $0.85 | 1,045,087 | D | P |
| 12 Dec, 2025 | Brent Pfeiffenberger | Common Stock | A | 52,000 | $0.58 | 3,322,990 | D | P |
| 10 Dec, 2025 | Brent Pfeiffenberger | Common Stock | D | 463 | $0.53 | 3,270,990 | D | F |
| 08 Dec, 2025 | Douglas Carr | Common Stock | D | 257 | $0.53 | 404,874 | D | S |
| 08 Dec, 2025 | Gregory Russotti | Common Stock | D | 526 | $0.53 | 390,982 | D | S |
| 20 Nov, 2025 | Chad Cowan | Common Stock | D | 5,462 | $0.50 | 987,027 | D | S |
| 19 Nov, 2025 | Brent Pfeiffenberger | Common Stock | A | 35,000 | $0.50 | 3,271,453 | D | P |
| 17 Nov, 2025 | Brent Pfeiffenberger | Common Stock | D | 32,456 | $0.45 | 3,236,453 | D | S |
| 03 Nov, 2025 | Douglas Carr | Common Stock | D | 292 | $0.59 | 405,131 | D | S |
| 18 Sep, 2025 | Chad Cowan | Common Stock | A | 762,543 | $0.00 | 992,489 | D | A |
| 08 Sep, 2025 | Douglas Carr | Common Stock | D | 263 | $0.50 | 405,423 | D | S |
| 08 Sep, 2025 | Gregory Russotti | Common Stock | D | 539 | $0.50 | 391,508 | D | S |
| 08 Sep, 2025 | Brent Pfeiffenberger | Common Stock | D | 488 | $0.50 | 3,268,909 | D | S |
| 14 Aug, 2025 | Brent Pfeiffenberger | Common Stock | A | 1,587,614 | $0.00 | 3,269,397 | D | A |